Synthetic atrial natriuretic factor in conscious normotensive and hypertensive rats.
- 1 May 1985
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 7 (3_pt_2), I35-42
- https://doi.org/10.1161/01.hyp.7.3_pt_2.i35
Abstract
Synthetic atrial natriuretic factor (Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly -Leu- Gly-Cys-Asn-Ser-Phe-Arg-Tyr-COOH [disulfide bond between cysteines]) was infused intravenously into conscious normotensive and deoxycorticosterone, one-kidney, one-clip, and two-kidney, one-clip hypertensive rats. Mean arterial pressure, urine volume, and electrolyte excretion rates were measured during a 20-minute infusion of a single dose (ranging from 0-1520 pmol/min) into each animal; 95 to 380 pmol/minute of synthetic atrial natriuretic factor maximally reduced mean arterial pressure by -20 +/- 4, -29 +/- 2, and -39 +/- 7 mm Hg in normotensive, one-kidney, one-clip, and two-kidney, one-clip hypertensive rats, respectively. In deoxycorticosterone rats, a dose of 760 pmol/minute was required to produce the largest depressor response (-58 +/- 12 mm Hg). Sodium excretion increased to 8.8 +/- 2.5 muEq/minute at 760 pmol/minute in normotensive rats, to 6.5 +/- 1.1 muEq/minute at 50 pmol/minute in deoxycorticosterone rats, and to 5.8 +/- 1.5 muEq/minute at 95 pmol/minute in one-kidney, one-clip animals. The natriuretic effect was consistently greater at all doses of synthetic atrial natriuretic factor in the two-kidney, one-clip hypertensive model, in which the maximum response was 15.3 +/- 4.7 muEq/minute at 190 pmol/minute. The changes in urine volume and excretion rates of potassium and chloride tended to parallel the increases in sodium excretion in each model. Interestingly, the maximally effective hypotensive dose of synthetic atrial natriuretic factor was different from the maximally effective natriuretic dose in all four groups.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 22 references indexed in Scilit:
- Renal and systemic effects of synthetic atrial natriuretic factorLife Sciences, 1985
- Isolation and sequence determination of peptide components of atrial natriuretic factorBiochemical and Biophysical Research Communications, 1984
- Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility.Hypertension, 1984
- Rat atrial natriuretic factor: Complete amino acid sequence and disulfide linkage essential for biological activityBiochemical and Biophysical Research Communications, 1984
- Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)Biochemical and Biophysical Research Communications, 1984
- Natriuretic effect of atrial extract on isolated perfused rat kidneyCanadian Journal of Physiology and Pharmacology, 1983
- The amino acid sequence of an atrial peptide with potent diuretic and natriuretic propertiesBiochemical and Biophysical Research Communications, 1983
- Bioactive Cardiac Substances: Potent Vasorelaxant Activity in Mammalian AtriaScience, 1983
- Relationship of specific granules to the natriuretic and diuretic activity of rat atriaCellular and Molecular Life Sciences, 1982
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981